Glyclopyramide

Preferred Label : Glyclopyramide;

NCIt definition : A second-generation sulfonylurea with antihyperglycemic activity. Compared to first-generation compounds and like other second-generation compounds, glyclopyramide works more effectively with fewer side effects. This agent has a relatively short half-life of 4.0 hours and is excreted mainly by the kidneys.;

UNII : KE474IKG1W;

InChIKey : HNSCCNJWTJUGNQ-UHFFFAOYSA-N;

CAS number : 631-27-6;

Drug name : Deamelin;

Chemical formula : C11H14ClN3O3S;

Details

Origin ID

C65808;

UMLS CUI

C0607456;

Automatic exact mappings (from CISMeF team)
- Glyclopyramide [ICHI extension code]
Currated CISMeF NLP mapping
- Glyclopyramide [ICD-11 Extension code]
- glyclopyramide [MeSH concept]
- glyclopyramide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Glyclopyramide [ICD-11 Extension code]
- glyclopyramide [MeSH concept]
- glyclopyramide [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients